Clemens Schulte's Avatar

Clemens Schulte

@clemensschulte.bsky.social

MSc. Biochemistry, Dr. rer. nat. | former grad student @hmariclab Peptides & Biophysics

21 Followers  |  23 Following  |  3 Posts  |  Joined: 24.01.2025  |  1.3985

Latest posts by clemensschulte.bsky.social on Bluesky

Video thumbnail

Folddisco finds similar (dis)continuous 3D motifs in large protein structure databases. Its efficient index enables fast uncharacterized active site annotation, protein conformational state analysis and PPI interface comparison. 1/9🧶🧬
📄 www.biorxiv.org/content/10.1...
🌐 search.foldseek.com/folddisco

07.07.2025 08:21 — 👍 153    🔁 70    💬 8    📌 3

Our eSylites are on the cover of the current #JACS issue! Check it out 👇

11.05.2025 12:27 — 👍 6    🔁 3    💬 1    📌 0

Make sure not to miss our latest paper out now in #JACS - presenting eSylites - small, peptide-based probes for precise mapping of neurons, etc.!

Microscale thermophoresis (MST) played a huge part in optimizing the probes structure and sequence for binding affinity.

#ChemicalBiology #Synapse

20.03.2025 19:35 — 👍 7    🔁 4    💬 0    📌 0

🚨 Excited to share our work @elife.bsky.social doi.org/10.7554/eLife.98827.2 on targeting Hepatitis B virus #HBV 🦠 capsid aggregation by designed molecules! #DrugDiscovery #ChemBio

Thanks V Khayenko C Makbul @clemensschulte.bsky.social & @boettchercryoem.bsky.social for stunning #CryoEM visuals!

28.01.2025 19:07 — 👍 15    🔁 3    💬 0    📌 1
Post image

#SIRT7 is a histone deacetylase with highly specific activity on #chromatin substrates.
We just published mechanism-based #cryoEM structures of #SIRT7 on nucleosomes to understand its activity 👇
www.nature.com/articles/s41...
(1/8) #ChemBio #ChemSky

04.02.2025 13:13 — 👍 43    🔁 17    💬 1    📌 1

Super excited to finally see the final version of this paper online 😁
Great team effort combining biophysics and #CryoEM for development of HepB aggregating compounds!
Huge thx to everyone involved!

01.02.2025 20:38 — 👍 2    🔁 0    💬 0    📌 0
Preview
PROTAC protein degraders to drug the undruggable enter phase 3 trials Pharmaceutical companies are investing in therapies that target proteins for degradation, with trials ongoing for cancer, autoimmune diseases and neurological disorders.

www.nature.com/articles/d41...

24.01.2025 20:33 — 👍 1    🔁 0    💬 0    📌 0

@clemensschulte is following 20 prominent accounts